ReutersThe Serum Institute of India is preparing to produce Novavax's COVID-19 vaccine in the country, government official Vinod Kumar Paul said at a press briefing on Tuesday.
The vaccine maker on Monday had said its COVID-19 vaccine was more than 90 per cent effective in a large, late-stage US-based clinical trial.
The vaccine maker on Monday had said its COVID-19 vaccine was more than 90 per cent effective in a large, late-stage US-based clinical trial.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.